Loading…

Loading grant details…

Active HORIZON European Commission

Technology-driven combinatorial therapy to rewire the spinal cord after injury


Funder European Commission
Recipient Organization Dwi Leibniz-Institut Fur Interaktive Materialien Ev
Country Germany
Start Date Jan 01, 2023
End Date Dec 31, 2026
Duration 1,460 days
Number of Grantees 24
Roles Associated Partner; Participant; Coordinator
Data Source European Commission
Grant ID 101073374
Grant Description

ReWIRE will combine innovative translational neurotechnologies and rehabilitation interventions for the repair and restoration of neurological functions following injury of the spinal cord (SC).

The proposed research program will equip next-generation scientists with unique skills to develop disruptive therapeutic solutions for patients with paralysis.

Recent technological breakthroughs have triggered a paradigm shift in the conception of therapies aimed to restore function after spinal cord injury (SCI).

Novel drug delivery systems and biomaterial bridges have been engineered to reduce secondary injury and scarring, to stimulate and guide regenerating nerve fibres across the lesion site, and to promote functional reconnection with intact tissue.

Additionally, neuromodulation therapies can reactivate spinal circuits below a SCI, allowing people with chronic paralysis to regain voluntary control of walking.

In conjunction with rehabilitation, neurological recovery was promoted that persisted without neuromodulation, suggesting a rewiring of the SC as demonstrated in preclinical models.

To bypass an injury, neuromodulation has been linked to brain signals to re-establish cortical control over spinal circuits by employing electrical nerve stimulation and robotic systems.

Advances in robotics are significantly augmenting the impact of neurorehabilitation by inducing new natural “wired” connections.

The aim of ReWIRE is to leverage all these technical and therapeutic breakthroughs in the framework of multiple PhD projects that will continuously interact to converge toward effective combinatorial treatments for SCI.

ReWIRE will focus on three inter-woven objectives: i) establish an international, interdisciplinary, and intersectoral educational network, ii) build an SCI clinical data platform, and, iii) position Europe at the forefront of therapy for SCI.

All Grantees

University of British Columbia; Aachen Proteineers Gmbh; Deutsches Zentrum Fur Neurodegenerative Erkrankungen Ev; Universitaetsklinikum Aachen; Johannes Gutenberg-Universitat Mainz; Biosynth Bv; Imperial College of Science Technology and Medicine; Koninklijke Nederlandse Akademie Van Wetenschappen - Knaw; Rheinisch-Westfaelische Technische Hochschule Aachen; Dwi Leibniz-Institut Fur Interaktive Materialien Ev; Commissariat A L Energie Atomique Et Aux Energies Alternatives; Technische Universitat Hamburg; Creoptix Ag; Myoswiss Ag; Ecole Polytechnique Federale de Lausanne; Centre Hospitalier Universitaire Vaudois; Scuola Superiore Di Studi Universitari E Di Perfezionamento S Anna; Onward Medical Nv; Wearable Robotics S.R.L.; Pepscan Therapeutics Bv; Universitat Zurich; The Regents of the University of California; Technische Universiteit Eindhoven; King's College London

Advertisement
Discover thousands of grant opportunities
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant